As you can imagine, security was quite tight at the convention center during the BIO2007 conference. This was especially evident on Tuesday during the visit of Her Majesty Queen Noor of Jordan. Special Operations officers lined the walkways — I would post a picture but they asked that I not photograph them. Because of an […]
On Tuesday late afternoon, a few lone protesters across the street from the BIO2007 International Convention at the Boston convention center caught my eye as they were holding up a large banner that read: “Life Is Not Patentable.” I really wanted to know why they were against patents. I made my way over to their […]
While attending BIO2007 in Boston on May 6-9 and will be participating as a blogger on-site at BioVoice, the BIO2007 Conference Exhibitor Hall has been jam-packed with events. With 1,900 exhibitors, 60 pavilions and 60 countries available to stop by and visit, it’s difficult to meet with all those you want and to spend enough […]
On the same day that the Supreme Court seemed to rely on common sense in its approach in the KSR decision, it handed down its holding in Microsoft Corp. v. AT&T Corp, No. 05.1056, 550 US ___ (April 30, 2007) which defies common sense. The lesson learned from this decision is to either file for […]
I will be attending BIO2007 in Boston on May 6-9 and will be participating as a blogger on-site at BioVoice, an up-to-the-minute review of some of the sites and sounds at the largest gathering of biotech professionals in the world with over 20,000 attendees, 1,900 exhibitors, 60 pavilions, 60 countries represented and 300 public officials. […]
Earlier, we discussed the moves by Brazil towards breaking the patent on Merck’s efavirenz anti-retroviral drug (See Patents Are For Chumps) after declaring it a “public interest” medicine, which effectively gave Merck seven days to negotiate lower prices with the government or have Brazil break the patent by issuing a compulsory license. More recently, things […]
It is clear that the Supreme Court’s ruling in KSR Int’l Co. v. Teleflex Inc. (Opinion 04-1350; Decided April 30, 2007) was meant to make it easier to challenge a patent on the grounds that the idea was obvious or showed no real innovation. The question is, does this mean bad news for pharmaceutical and […]
Just an update on KSR Int’l Co. v. Teleflex Inc. (Opinion 04-1350; Decided April 30, 2007). KSR has been the most anticipated patent law case in the past year and will certainly be discussed for months and years to come. Many are wondering if this will give a boost to businesses by getting rid of […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
